(±)-threo-3-Methylglutamic acid

Names

[ CAS No. ]:
63088-04-0

[ Name ]:
(±)-threo-3-Methylglutamic acid

[Synonym ]:
(±)-threo-3-Methylglutamic acid

Chemical & Physical Properties

[ Density]:
1.329g/cm3

[ Boiling Point ]:
329.4ºC at 760 mmHg

[ Molecular Formula ]:
C₆H₁₁NO₄

[ Molecular Weight ]:
161.15600

[ Flash Point ]:
153ºC

[ Exact Mass ]:
161.06900

[ PSA ]:
100.62000

[ LogP ]:
0.20940

[ Appearance of Characters ]:
white to off-white

[ Index of Refraction ]:
1.512

[ Storage condition ]:
Store at RT

[ Water Solubility ]:
H2O: >1.5mg/dL

MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H315-H319-H335

[ Precautionary Statements ]:
P261-P305 + P351 + P338

[ Hazard Codes ]:
Xi

[ Risk Phrases ]:
36/37/38

[ Safety Phrases ]:
26

[ RIDADR ]:
NONH for all modes of transport

[ HS Code ]:
2922499990

Customs

[ HS Code ]: 2922499990

[ Summary ]:
HS:2922499990 other amino-acids, other than those containing more than one kind of oxygen function, and their esters; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:AB(certificate of inspection for goods inward,certificate of inspection for goods outward) MFN tariff:6.5% General tariff:30.0%

Articles

Guide to Receptors and Channels (GRAC), 4th Edition.

Br. J. Pharmacol. 158 Suppl 1 , S1-254, (2009)

In vitro comparison of the effect of inhalation delay and flow rate on the emitted dose from three valved holding chambers.

J. Aerosol Med. Pulm. Drug Deliv. 27 Suppl 1 , S37-43, (2014)

Valved holding chambers (VHCs) are accessory devices for pressurized metered dose inhalers (pMDIs). Use of a VHC may help overcome coordination issues associated with drug delivery via the pMDI alone....

(2R,3S)-3-Methylglutamic acid
(2s,3s)-3-Methylglutamic acid
(±)-3-methyl-2-oxovaleric acid sodium salt
(±)-3-(fmoc-amino)-2-phenylpropionic acid
(±)-3-(4-chlorophenyl)-2-phenylpropanoic acid
(±)-3-((1-phenylethoxy)carbonyl)propanoic acid
N-(2,4-dimethylphenyl)-1-(3,4-dimethylphenyl)-5-(pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamide
N-(4-{1-[(allylamino)carbonyl]cyclobutyl}phenyl)-4-methylbenzamide
N-(2,4-dimethoxyphenyl)-1-(3,4-dimethylphenyl)-5-(pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamide
1-Benzyloxy-2-(1,1-difluoroethyl)benzene
N-(4-ethylphenyl)-2-(4-(3-fluorophenyl)-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-e][1,2,4]thiadiazin-2-yl)acetamide
N-(2-chloro-4-methylphenyl)-1-(3,4-dimethylphenyl)-5-(pyridin-3-yl)-1H-1,2,3-triazole-4-carboxamide
N-(2-chlorophenyl)-2-(4-(3-fluorophenyl)-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-e][1,2,4]thiadiazin-2-yl)acetamide
2-(4-(3-fluorophenyl)-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-e][1,2,4]thiadiazin-2-yl)-N-(p-tolyl)acetamide
2-(4-(3-fluorophenyl)-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-e][1,2,4]thiadiazin-2-yl)-N-(2-methoxyphenyl)acetamide
N-(3,4-dimethylphenyl)-2-(4-(3-fluorophenyl)-1,1-dioxido-3,4-dihydro-2H-pyrido[2,3-e][1,2,4]thiadiazin-2-yl)acetamide

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.